Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIAP pilot open-label study in steroid-refractory fulminant ulcerative colitis
NL-OMON21005Active, not recruiting
- Sponsor
- AM-Pharma B.V. Rumpsterweg 6 3981 AK Bunnik THE NETHERLANDS Telephone: +31 (0)30 228 9 222 Telefax: +31 (0)30 228 9 220
- Start
- Dec 2006
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of bovine intestinal alkaline phosphatase in autoimmune colitis, sponsored by AM-Pharma B.V. Rumpsterweg 6 3981 AK Bunnik THE NETHERLANDS Telephone: +31 (0)30 228 9 222 Telefax: +31 (0)30 228 9 220. Started Dec 2006; status: active, not recruiting.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on NL-OMON21005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21005.